DE69231291D1 - Impfsystem mit einer einzeldosis - Google Patents
Impfsystem mit einer einzeldosisInfo
- Publication number
- DE69231291D1 DE69231291D1 DE69231291T DE69231291T DE69231291D1 DE 69231291 D1 DE69231291 D1 DE 69231291D1 DE 69231291 T DE69231291 T DE 69231291T DE 69231291 T DE69231291 T DE 69231291T DE 69231291 D1 DE69231291 D1 DE 69231291D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- water
- biologically active
- active material
- implantation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPK526891 | 1991-03-26 | ||
PCT/AU1992/000124 WO1992017165A1 (en) | 1991-03-26 | 1992-03-25 | A single dose vaccination system |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231291D1 true DE69231291D1 (de) | 2000-08-31 |
DE69231291T2 DE69231291T2 (de) | 2001-01-18 |
Family
ID=3775296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231291T Expired - Fee Related DE69231291T2 (de) | 1991-03-26 | 1992-03-25 | Impfsystem mit einer einzeldosis |
Country Status (8)
Country | Link |
---|---|
US (1) | US5593697A (de) |
EP (1) | EP0576522B1 (de) |
AT (1) | ATE194910T1 (de) |
CA (1) | CA2106952C (de) |
DE (1) | DE69231291T2 (de) |
ES (1) | ES2149174T3 (de) |
NZ (2) | NZ286242A (de) |
WO (1) | WO1992017165A1 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5358502A (en) * | 1993-02-25 | 1994-10-25 | Pfizer Inc | PH-triggered osmotic bursting delivery devices |
DE69432665T3 (de) * | 1993-03-29 | 2007-12-06 | Pfizer Inc. | Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt |
DE69528450T2 (de) * | 1994-02-18 | 2003-01-23 | Solidose L L C | Impfung von tieren mit getrockneten pelletierten biologischen materialien |
NZ288144A (en) * | 1994-06-22 | 1998-12-23 | Unasco Pty | Active agent sustained release capsule: fluid expandable layers and active agent layers |
FR2723536A1 (fr) * | 1994-08-11 | 1996-02-16 | Seth Pawan | Composition permettant une liberation selective d'un principe actif |
AUPM897594A0 (en) * | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
US6143037A (en) * | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
US6140475A (en) | 1997-04-11 | 2000-10-31 | Altus Biologics Inc. | Controlled dissolution crosslinked protein crystals |
CN100548279C (zh) * | 1997-10-09 | 2009-10-14 | 德克塞尔药物技术有限公司 | 延迟的总释放胃肠道给药系统 |
US6541606B2 (en) * | 1997-12-31 | 2003-04-01 | Altus Biologics Inc. | Stabilized protein crystals formulations containing them and methods of making them |
ID26963A (id) * | 1998-03-02 | 2001-02-22 | Applied Vaccine Technologies C | Metoda dan alat untuk memodulasi respon kekebalan |
US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
ATE269114T1 (de) | 1998-11-20 | 2004-07-15 | Univ Connecticut | Verfahren und vorrichtung zur steuerung der gewebeimplantat-interaktionen |
US20030099682A1 (en) * | 1998-11-20 | 2003-05-29 | Francis Moussy | Apparatus and method for control of tissue/implant interactions |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US20040121014A1 (en) * | 1999-03-22 | 2004-06-24 | Control Delivery Systems, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6632451B2 (en) | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US7030097B1 (en) | 1999-07-14 | 2006-04-18 | Cornell Research Foundation, Inc. | Controlled nucleic acid delivery systems |
US6592869B2 (en) * | 1999-08-24 | 2003-07-15 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
DK1212045T3 (en) | 1999-08-24 | 2016-11-28 | Abic Biological Laboratories Ltd | VACCINE COMPOSITION AND METHOD OF USING IT |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
DE10035156A1 (de) * | 2000-07-19 | 2002-02-07 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Proteinkomplex als Vehikel für oral verfügbare Protein-Arzneimittel |
US7575780B2 (en) * | 2000-08-07 | 2009-08-18 | Orthogen Llc | Method for manufacturing particles for use in forming a resorbable implant for stimulating bone growth |
GB0025208D0 (en) * | 2000-10-13 | 2000-11-29 | Euro Celtique Sa | Delayed release pharmaceutical formulations |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
WO2003092633A2 (en) | 2002-05-06 | 2003-11-13 | Massachusetts Institute Of Technology | Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
US8871241B2 (en) * | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
US20050152939A1 (en) * | 2002-05-22 | 2005-07-14 | Bunt Craig R. | Delivery technology |
WO2003101483A1 (en) * | 2002-05-31 | 2003-12-11 | Solux Corporation | Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use |
KR100628263B1 (ko) * | 2002-08-21 | 2006-09-27 | 엘지.필립스 엘시디 주식회사 | 액정표시소자 |
US7452350B2 (en) * | 2003-07-09 | 2008-11-18 | Yeakley Rourke M | Pre-dosed oral liquid medication dispensing system |
EP3081214A3 (de) * | 2003-08-29 | 2016-11-16 | The Brigham And Women's Hospital, Inc. | Zellnekrosehemmer |
US20060280795A1 (en) * | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system |
WO2007025191A1 (en) | 2005-08-23 | 2007-03-01 | Smith & Nephew, Inc. | Telemetric orthopaedic implant |
WO2007084587A2 (en) * | 2006-01-20 | 2007-07-26 | Monosol Rx, Llc | Film lined pouch and method of manufacturing this pouch |
US9849216B2 (en) * | 2006-03-03 | 2017-12-26 | Smith & Nephew, Inc. | Systems and methods for delivering a medicament |
CN101534799A (zh) * | 2006-09-29 | 2009-09-16 | 莫诺索尔克斯有限公司 | 膜埋入式包装及其制备方法 |
JP2012513481A (ja) | 2008-12-23 | 2012-06-14 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | ネクロトーシスの小分子阻害剤 |
CN102740830A (zh) * | 2009-12-23 | 2012-10-17 | 普西维达公司 | 缓释递送装置 |
US8206368B2 (en) * | 2010-01-18 | 2012-06-26 | Rourke M. Yeakley | Multi-chamber mixture dispensing system |
US8109917B2 (en) * | 2010-01-18 | 2012-02-07 | Rourke M. Yeakley | Twistable medication dispensing system |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
ES2675307T3 (es) | 2011-12-22 | 2018-07-10 | Centre Hospitalier Universitaire Vaudois (Chuv) | Activación selectiva con plasma para implantes médicos y dispositivos de cicatrización de heridas |
PT3326611T (pt) | 2012-02-22 | 2020-08-20 | Duchesnay Inc | Formulação de doxilamina e piridoxina e/ou seus metabolitos ou sais |
US9717583B2 (en) | 2014-03-13 | 2017-08-01 | Cell and Molecular Tissue Engineering, LLC | Sensors, cannulas, collars and coated surgical mesh, and corresponding systems and methods |
US10130760B2 (en) * | 2013-03-15 | 2018-11-20 | Incube Labs, Llc | Multi-stage biodegradable drug delivery platform |
US9725452B2 (en) | 2013-03-15 | 2017-08-08 | Presidents And Fellows Of Harvard College | Substituted indoles and pyrroles as RIP kinase inhibitors |
WO2015010194A1 (en) | 2013-07-22 | 2015-01-29 | Duchesnay Inc. | Composition for the management of nausea and vomiting |
CA2970525A1 (en) | 2014-12-11 | 2016-06-16 | President And Fellows Of Harvard College | Inhibitors of cellular necrosis and related methods |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
CA3022840A1 (en) | 2016-05-05 | 2017-11-09 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
FR2454804B1 (fr) * | 1979-04-26 | 1986-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
ZA86252B (en) * | 1985-01-30 | 1986-09-24 | Warner Lambert Co | Coated dosage forms |
DE3678641D1 (de) * | 1985-08-16 | 1991-05-16 | Procter & Gamble | Partikel mit konstanter wirkstofffreisetzung. |
DE3684446D1 (de) * | 1985-12-28 | 1992-04-23 | Sumitomo Pharma | Arzneimittel mit verzoegerter stossweiser freisetzung. |
EP0270575A4 (de) * | 1986-05-16 | 1988-10-20 | Victoria State | Biocompatible implantate. |
JPH04504122A (ja) * | 1989-03-17 | 1992-07-23 | ピットマン―ムーア・インコーポレイテッド | 巨大分子タンパク質の制御放出考案物 |
US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
EP0408496A3 (en) * | 1989-07-12 | 1992-07-01 | Ciba-Geigy Ag | Solid dosage form for pharmaceutical substances |
JPH03197421A (ja) * | 1989-12-26 | 1991-08-28 | Takeda Chem Ind Ltd | 徐放性錠剤 |
US5091185A (en) * | 1990-06-20 | 1992-02-25 | Monsanto Company | Coated veterinary implants |
-
1992
- 1992-03-19 NZ NZ286242A patent/NZ286242A/en unknown
- 1992-03-19 NZ NZ242065A patent/NZ242065A/en unknown
- 1992-03-25 US US08/119,174 patent/US5593697A/en not_active Expired - Fee Related
- 1992-03-25 ES ES92907229T patent/ES2149174T3/es not_active Expired - Lifetime
- 1992-03-25 WO PCT/AU1992/000124 patent/WO1992017165A1/en active IP Right Grant
- 1992-03-25 AT AT92907229T patent/ATE194910T1/de not_active IP Right Cessation
- 1992-03-25 EP EP92907229A patent/EP0576522B1/de not_active Expired - Lifetime
- 1992-03-25 CA CA002106952A patent/CA2106952C/en not_active Expired - Fee Related
- 1992-03-25 DE DE69231291T patent/DE69231291T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2106952C (en) | 2003-01-21 |
NZ286242A (en) | 1997-11-24 |
DE69231291T2 (de) | 2001-01-18 |
WO1992017165A1 (en) | 1992-10-15 |
EP0576522A1 (de) | 1994-01-05 |
US5593697A (en) | 1997-01-14 |
ES2149174T3 (es) | 2000-11-01 |
CA2106952A1 (en) | 1992-09-27 |
NZ242065A (en) | 1996-06-25 |
EP0576522A4 (en) | 1994-06-01 |
EP0576522B1 (de) | 2000-07-26 |
ATE194910T1 (de) | 2000-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69231291D1 (de) | Impfsystem mit einer einzeldosis | |
ATE109000T1 (de) | System zur freisetzung von medikamenten und dessen herstellungsmethode. | |
DE69229949D1 (de) | Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe | |
GR880100619A (el) | Μεθοδος παρασκευης πολυπεπτιδιων αδιαλυτων εις υδωρ | |
ATE225165T1 (de) | Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel | |
MY113488A (en) | Compounds with growth hormone releasing properties | |
DE69519685D1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
IL84167A (en) | Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation | |
NO884474D0 (no) | Implanterbart, biologisk nedbrytbart virkestoff-frigjoeringssystem. | |
EP0778047A3 (de) | Intramuskuläre Stimulationsleitung mit Abwehreigenschaften gegen Infektionen | |
DE69101710D1 (de) | Arzneimittel freisetzendes polymeres system. | |
ATE69725T1 (de) | Pharmazeutische zubereitungen von acrivastine. | |
NZ221575A (en) | A microgranular preparation for intestinal delivery of biologically active materials in animals | |
CA2202499A1 (en) | Renibacterium salmoninarum vaccine and method for its preparation | |
IL115138A (en) | Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof | |
IT8220758A1 (it) | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli | |
US3796217A (en) | Drug release system | |
CA2000932A1 (en) | Oral pharmaceutical controlled release multiple unit dosage form | |
IE791966L (en) | Microparticle drug delivery | |
CA2019779A1 (en) | Intermittent release dosage form | |
DK0871467T3 (da) | Ny formulering til afgivelse af peptid | |
CA2065847A1 (en) | Rotavirus reassortant vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |